HealthData.Gov
Angiotensin receptor blockers in heart failure after the ELITE II trial
Specific blockers of the angiotensin type1 receptor, angiotensin receptor blockers (ARBs), have been introduced as an alternative to angiotensin-converting enzyme inhibitors (ACEi) for the treatment of heart failure. In…
- HTML
Updated Oct 29, 2026